Login / Signup

Postmarketing safety surveillance of dexamethasone intravitreal implant in the treatment of visual impairment due to diabetic macular edema in India.

Unnikrishnan NairVishali GuptaMohita SharmaShrinivas JoshiAditya SudhalkarUndraa AltangerelYan Bainull null
Published in: BMC ophthalmology (2020)
World Health Organization Clinical Trials Registry: CTRI/2017/04/008396 . Registered 24 April 2017.
Keyphrases
  • clinical trial
  • public health
  • low dose
  • vascular endothelial growth factor
  • high dose
  • diabetic retinopathy
  • randomized controlled trial
  • replacement therapy
  • endothelial cells
  • study protocol